Wayzata, MN, United States of America

Richard L Lindstrom

This inventor holds 38 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Ophthalmic Treatments. Top assignees: Surface Ophthalmics, Inc., Glaukos Corporation, 3M Innovative Properties Company. Active years: 1986-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard L Lindstrom. Retrieved from https://idiyas.com/inventor/richard-l-lindstrom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 38 

% Patents Active = 97.4

 

 

Average Co-Inventor Count = 1.6

ph-index = 19

Forward Citations = 1,028(Granted Patents)


Location History:

  • Plymouth, MN (US) (1991 - 1993)
  • Excelsior, MN (US) (1987 - 1995)
  • Wayzata, MN (US) (1986 - 2019)
  • Minneapolis, MN (US) (2018 - 2020)
  • Pleasanton, CA (US) (2024)

Company Filing History:


Years Active: 1986-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Chondroitin Sulfate
Ocular Pain Relief
Ophthalmic Compositions
Intraocular Lens
Drug Delivery Systems
Corneal Implant
Viscoelastic Solution
Therapeutic Device
Multifocal Lens
Targeted Eye Drops
Corneal Enhancement
Irrigation Solution
38 patents (USPTO):Explore Patents

Title: Innovator Profile: Richard L Lindstrom

Introduction

Richard L Lindstrom is a prominent inventor based in Wayzata, MN, known for his significant contributions to the field of ophthalmology. With an impressive portfolio of 35 patents, Lindstrom has dedicated his career to developing innovative solutions for ocular disorders, enhancing patient care and treatment outcomes.

Latest Patents

Lindstrom's recent patents include a therapeutic device for pain management and vision. This groundbreaking therapeutic lens is designed to treat epithelial defects by incorporating a layer of therapeutic material that helps regulate water flow from the tear liquid, restoring corneal deturgescence to decrease swelling and light scattering. The lens not only protects nerve fibers to mitigate pain but also features an index of refraction that reduces light scatter, ultimately providing functional vision as the epithelium regenerates.

Another notable patent is focused on an implant delivery system and methods for treating ocular disorders, specifically glaucoma. The surgical technique encompasses trabecular bypass surgery, utilizing a stent implant that bypasses diseased trabecular meshwork. This innovative approach facilitates the improvement of fluid drainage within the eye, positioning the implant strategically to enhance patient outcomes.

Career Highlights

Throughout his career, Lindstrom has worked with esteemed organizations, including Glaukos Corporation, where he has played a critical role in advancing ocular treatment technologies. His commitment to innovation and excellence has positioned him as a leading figure in the field, known for his ability to transform complex medical challenges into practical and effective solutions.

Collaborations

Richard Lindstrom's journey has been marked by collaboration with talented professionals in the industry. Notably, he has worked alongside colleagues such as Debra L Skelnik and David S Haffner, sharing insights and expertise to drive advancements in ophthalmic technologies. These collaborations have further enriched his contributions to the field and fostered a spirit of innovation within his work environment.

Conclusion

With a remarkable track record of 35 patents and a steadfast dedication to improving ocular health, Richard L Lindstrom continues to be an influential figure in the realm of medical inventions. His cutting-edge innovations serve to enhance patient care and revolutionize treatment methodologies, underscoring the importance of ongoing research and development in the field of ophthalmology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…